Singapore eDevelopment

SINGAPORE (Jan 28): Singapore eDevelopment announced that its US biomedical subsidiary, Global BioLife, has a product – 3F Antimicrobial Fragrance – that shows efficacy against tuberculosis.

SINGAPORE (Feb 27): Singapore eDevelopment announced that its FY17 losses have narrowed by 26% to $5.29 million, compared to $7.18 million in FY16.

SINGAPORE (Aug 15): Global BioLife, the biomedical indirect subsidiary of Catalist-listed Singapore eDevelopment (SeD), is collaborating with US-based perfume manufacturer Chemia Corporation to develop a suite of functional fragrances for industrial and m

SINGAPORE (Aug 10): Property group Singapore eDevelopment reported half year losses widened to $6.3 million from $5.3 million a year ago.

SINGAPORE (April 3): Singapore eDevelopment says its independent auditor, Ernst & Young LLP, has included an emphasis of matter in its report on the audit of the financial statements of the group for the FY16 ended Dec.

SINGAPORE (March 16): Singapore eDevelopment says iGalen International Inc, the distributor of dietary supplements, achieved sales orders amounting to US$689,800 ($977,912) in the first 30 days of operations.

SINGAPORE (March 13): Singapore eDevelopment (SeD) has named senior members of its new biomedical management division, SeD BioMedical, that includes two-time Nobel Prize nominee Daryl Thompson.

SINGAPORE (Feb 14): Singapore eDevelopment says wholly-owned subsidiary in Singapore, Health Wealth Happiness, formerly known as SeD Global Investment, has acquired a 53% stake in iGalen International Inc. for a total consideration of US$53.

SINGAPORE (Dec 12): Here are some factors and stocks that could move the market this Monday morning:

SINGAPORE (Nov 24): Property developer and technology firm Singapore eDevelopment says its subsidiary has sold a 13-acre Ballenger Run land parcel to US regional homebuilder, Orchard Development Corporation (ODC), for US$5.25 million ($7.5 million).